Patent details

EP2841445 Title: 2.2-DIFLUOROPROPIONAMIDE DERIVATIVES OF BARDOXOLONE METHYL, POLYMORPHIC FORMS AND METHODS OF USE THEREOF

Basic Information

Publication number:
EP2841445
PCT Application Number:
US2013038064
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP137207080
PCT Publication Number:
WO2013163344
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
2.2-DIFLUOROPROPIONAMIDE DERIVATIVES OF BARDOXOLONE METHYL, POLYMORPHIC FORMS AND METHODS OF USE THEREOF
French Title of Invention:
DÉRIVÉS 2,2-DIFLUOROPROPIONAMIDE DE BARDOXOLONE MÉTHYLE, LEURS FORMES POLYMORPHES ET LEURS PROCÉDÉS D'UTILISATION
German Title of Invention:
2,2-DIFLUORPROPIONAMIDDERIVATE VON BARDOXOLONMETHYL, POLYMORPHE FORMEN DAVON UND VERFAHREN ZUR VERWENDUNG DAVON
SPC Number:
LUC00340

Dates

Filing date:
24/04/2013
Grant date:
14/06/2017
EP Publication Date:
04/03/2015
PCT Publication Date:
31/10/2013
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
14/06/2017
EP B1 Publication Date:
14/06/2017
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
24/04/2033
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
14/11/2022
 
 

Name:
REATA PHARMACEUTICALS HOLDINGS, LLC
Address:
5320 Legacy Drive, Plano, 75024, Texas, Texas, United States (US)

History of Owners

From:
14/06/2017
To:
14/11/2022

Name:
Reata Pharmaceuticals, Inc.
Address:
2801 Gateway Drive, Suite 150, Irving, TX 75063-2648, United States (US)

Agent

Name:
VENI GMBH
From:
28/08/2017
Address:
CHAPEL HOUSE, 5 SHAW BRIDGE STREET, CLITHEROE BB7 1LY, United Kingdom (GB)
To:

Inventor

1

Name:
LIU, Xiaofeng
Address:
United States (US)

2

Name:
DECKER, Andrea
Address:
Switzerland (CH)

3

Name:
ANDERSON, Eric
Address:
United States (US)

Priority

1

Priority Number:
201261687669 P
Priority Date:
27/04/2012
Priority Country:
United States (US)

2

Priority Number:
201361775288 P
Priority Date:
08/03/2013
Priority Country:
United States (US)

3

Priority Number:
201361780444 P
Priority Date:
13/03/2013
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/565; A61P 29/00; C07J 63/00;

Publication

Bulletin

Bulletin Heading:
CO
Bulletin edition number:
2022/13
Publication date:
01/12/2022
Description:
Section M : Transfers of property (Art. 53 of the law), change of name and/or address

European Patent Bulletin

1

Issue number:
201724
Publication date:
14/06/2017
Description:
Grant (B1)

2

Issue number:
201729
Publication date:
19/07/2017
Description:
Application number/publication number of the divisional application (Art. 76) changed

Deed

Power of attorney

Change Kind/ Decision Type:
Assignment
Deed Number:
RC20170000320A
Date Registered:
28/08/2017
Licence Effective Date:
Licence Expiration Date:
Scope of Licence:
Deed Filer:
VENI GMBH
Journal Edition Number:
Text:
Country Code:
Updated Licence Number:
Terminated Licence Number:

Removed Pledgee

Name:
Address:

Change of owner(s)

Change Kind/ Decision Type:
Change of ownership
Deed Number:
RC20220000454A
Date Registered:
14/11/2022
Licence Effective Date:
Licence Expiration Date:
Scope of Licence:
Deed Filer:
Dennemeyer & Associates S.A.
Journal Edition Number:
Text:
Country Code:
Updated Licence Number:
Terminated Licence Number:

Added Owner(s)

Name:
REATA PHARMACEUTICALS HOLDINGS, LLC
Address:
5320 Legacy Drive, Plano, 75024, Texas, United States (US)

Removed Pledgee

Name:
Address:

Annual Fees

Annual Fee Due Date:
30/04/2026
Annual Fee Number:
14
Annual Fee Amount:
198 Euro
Expected Payer:
Last Annual Fee Payment Date:
19/03/2025
Last Annual Fee Paid Number:
13
Last Annual Fee Paid Amount:
180 Euro
Payer:
ANAQUA SERVICES (ANC. SGA2)
Filing date Document type Number of pages
14/11/2022 Request For Change 49
14/11/2022 Outgoing Correspondence 1
07/09/2017 Outgoing Correspondence 1
28/08/2017 Request For Change 3